Vytorin on Carotid Intima-media Thickness and Overall Rigidity.

Trial Profile

Vytorin on Carotid Intima-media Thickness and Overall Rigidity.

Completed
Phase of Trial: Phase IV

Latest Information Update: 05 Oct 2011

At a glance

  • Drugs Ezetimibe; Ezetimibe/simvastatin; Pravastatin; Simvastatin
  • Indications Atherosclerosis
  • Focus Pharmacodynamics
  • Acronyms VYCTOR
  • Most Recent Events

    • 05 Oct 2011 Actual end date (Dec 2005) added as reported by ClinicalTrials.gov.
    • 05 Oct 2011 Company (Merck) added as trial sponsor as reported by ClinicalTrials.gov.
    • 05 Oct 2011 Additional lead trial centre (Hospital Universitario 12 de Octubre) and investigator (Alejandra Meaney) identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top